Treatments that target the renin-angiotensin-aldosterone system (RAAS) don’t improve outcomes in adult patients hospitalized with acute COVID-19. Three separate trials of different RAAS-related ...
In a recent study posted to the medRxiv* preprint server, researchers conducted an umbrella review and meta-analysis of the renin-angiotensin-aldosterone system (RAAS) inhibitors' impact on ...
Please provide your email address to receive an email when new articles are posted on . Many international medical societies have endorsed the continuation of renin-angiotensin-aldosterone system ...
Investigators found no definitive benefit of dual RAAS blockade in preventing kidney failure in patients with ADPKD. For patients with autosomal dominant polycystic kidney disease (ADPKD), intensive ...
A woman reaching for a prescription bottle in a medicine cabinet Discontinuation of RAAS inhibitors is often the first approach to manage hyperkalemia. Discontinuation of renin–angiotensin-aldosterone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback